Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT02357459

Public ClinicalTrials.gov record NCT02357459. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to assess the safety and efficacy of FX006 for the treatment of pain in patients with osteoarthritis of the knee.

Study identification

NCT ID
NCT02357459
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
486 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2015 (Actual)
Primary completion
Jan 2016 (Actual)
Completion
Jan 2016 (Actual)
Last update posted
Jan 24, 2024

2015 – 2016

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Not listed Phoenix Arizona 85023 —
Not listed Tucson Arizona 85712 —
Not listed Anaheim California 92801 —
Not listed Canoga Park California 91303 —
Not listed North Hollywood California 91606 —
Not listed San Diego California 92103 —
Not listed Denver Colorado 80209 —
Not listed Atlantis Florida 33462 —
Not listed DeLand Florida 32720 —
Not listed Hialeah Florida 33012 —
Not listed Sarasota Florida 34232 —
Not listed West Palm Beach Florida 33409 —
Not listed Prairie Village Kansas 66206 —
Not listed Albuquerque New Mexico 87102 —
Not listed Cary North Carolina 27518 —
PMG Research of Cary Cary North Carolina — —
Not listed Charlotte North Carolina 28209 —
Not listed Duncansville Pennsylvania 16635 —
PMG Research of Knoxville Knoxville Tennessee 37912 —
PMG Research of Knoxville Knoxville Tennessee 37938 —
Not listed Dallas Texas 75231 —
Not listed Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02357459, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 24, 2024 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02357459 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →